NewTimeSpace News: Guotai Haitong signed a formal agreement on 27 July 2026 to sell its 24.99% stake in Shanghai Securities to Orient Securities as part of a RMB 25.12 billion deal for 100% of Shanghai Securities, under which Guotai Haitong will receive 457.48 million Orient Securities A-shares and RMB 1.57 billion in cash, exiting its direct holding while expecting to book a gain of about RMB 29.7 million.
NewTimeSpace News: Broncus Holding announced that its BroncTru® disposable bronchoscopic dilation catheter has obtained EU MDR CE certification, marking significant progress in the company's international registration and global product deployment. The product has already secured approvals from NMPA, FDA, and EU CE, and is cleared for sale in Taiwan, Indonesia, Thailand, and Malaysia.
By the close of trading on Jul 27, 2026, MINIMAX-W(00100.HK) saw a gain of 17.14% in its share price, closing at HKD 229.6. During the session, it reached an intraday high of HKD 231.8 and touched an intraday low of HKD 186.2.
HAIER SMARTHOME(06690.HK) will spend CNY 45.98 million to repurchase 2.1 million shares on Jul 27, 2026 .
By the close of trading on Jul 27, 2026, TH MEDICAL-B(02697.HK) saw a gain of 9.85% in its share price, closing at HKD 602. During the session, it reached an intraday high of HKD 620 and touched an intraday low of HKD 543.5.
NewTimeSpace News: Asia Financial Holdings Limited (00662.HK) announced on 27 July the appointment of Liao Haoxuan as Chief Financial Officer, effective immediately. Mr. Liao is a certified accountant in Hong Kong and the United Kingdom, with financial experience at investment management firms and global professional services firms.
NewTimeSpace News: InnoCare Pharma Limited (09969.HK) announced that the pivotal Phase III registration trial of fadeucravacitinib (ICP-488), a potent and highly selective TYK2 allosteric inhibitor, for patients with moderate to severe plaque psoriasis has successfully met the statistically significant primary endpoint and delivered clinically meaningful improvements. The safety profile is consistent with previous studies with no new safety signals identified.
NewTimeSpace News: Extreme Vision disclosed in an announcement dated 27 July that the Group expects its revenue for the first half of 2026 to reach approximately RMB 153 million to RMB 165 million, representing a year-on-year increase of 160% to 180%. The maximum non-IFRS adjusted net profit is projected at around RMB 6 million.
NewTimeSpace News: China Glass Holdings disclosed in an announcement dated 27 July that the Group expects to record a net profit of approximately RMB 35 million to RMB 65 million for the six months ended 30 June 2026, swinging from a loss of around RMB 318.7 million in the corresponding period last year.
NewTimeSpace News: Anhui Expressway disclosed in an announcement dated 27 July that, pursuant to the approval granted by the China Securities Regulatory Commission (CSRC), the Board of Directors intends to publicly offer Phase I 2026 corporate bonds to professional investors in mainland China with an aggregate principal amount not exceeding RMB 800 million. Tranche 1 carries a 3-year tenor, and Tranche 2 has a 5-year tenor.
NewTimeSpace News: HBM Holdings announced on July 27 that the Company has signed a strategic cooperation agreement with Sinopharm Group.
NewTimeSpace News: On 27 July, CITIC SEC(06030.HK) announced that its controlled subsidiary China Asset Management Co., Ltd. recorded revenue of RMB5.708 billion and net profit of RMB1.413 billion in the first half of 2026, with AUM reaching RMB2.91 trillion. The figures are unaudited.
NewTimeSpace News: Transport Internationa announced in a filing dated 27 July that Mr. Yu Huizhang will retire from his posts as Company Secretary and Authorised Representative, with effect from 1 August 2026. Ms. Cheng Wai Chung has been appointed as the new Company Secretary and Authorised Representative, effective the same date.
NewTimeSpace News: On 27 July, Yuexiu Property Company Limited (00123.HK) announced that its subsidiary plans to issue Phase 3 corporate bonds of up to RMB2 billion consisting of 5-year and 7-year tranches with interest rate adjustment, put and call provisions. The bonds carry AAA credit rating and proceeds will be utilised for debt repayment. Interest rates will be determined via bookbuilding.
NewTimeSpace News: On 27 July, Sino Biopharmaceutical Limited (01177.HK) announced the establishment of a joint venture with Indonesia’s Tempo Scan with a 51% equity stake to develop the innovative drug market across Southeast Asia. Tempo Scan has operated in Indonesia for over 70 years with 16 production bases and 238 distribution outlets. Registration and listing procedures for the initial batch of products are underway. Indonesia’s pharmaceutical market enjoys an annual growth rate of 8%-10%.
NewTimeSpace News: On 27 July 2026, Shenzhen Express(00548.HK) announced that it completed the issuance of RMB1 billion super short-term commercial paper on 24 July 2026. The notes carry a term of 270 days and an interest rate of 1.41%. China CITIC Bank acts as the bookrunner and lead underwriter, with Industrial Bank Co., Ltd. as joint lead underwriter.
